Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)

SHA:688266 Statistics

Total Valuation

SHA:688266 has a market cap or net worth of CNY 26.65 billion. The enterprise value is 25.76 billion.

Market Cap	26.65B
Enterprise Value	25.76B

Important Dates

The last earnings date was Saturday, March 28, 2026.

Earnings Date	Mar 28, 2026
Ex-Dividend Date	n/a

Share Statistics

SHA:688266 has 264.71 million shares outstanding. The number of shares has decreased by -0.85% in one year.

Current Share Class	264.71M
Shares Outstanding	264.71M
Shares Change (YoY)	-0.85%
Shares Change (QoQ)	-10.73%
Owned by Insiders (%)	23.63%
Owned by Institutions (%)	29.01%
Float	176.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	114.64
PS Ratio	32.89
PB Ratio	24.67
P/TBV Ratio	25.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-158.06
EV / Sales	31.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-122.50

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.05.

Current Ratio	1.71
Quick Ratio	1.54
Debt / Equity	1.05
Debt / EBITDA	n/a
Debt / FCF	-5.39
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -14.16% and return on invested capital (ROIC) is -5.42%.

Return on Equity (ROE)	-14.16%
Return on Assets (ROA)	-4.09%
Return on Invested Capital (ROIC)	-5.42%
Return on Capital Employed (ROCE)	-12.68%
Weighted Average Cost of Capital (WACC)	5.14%
Revenue Per Employee	890,642
Profits Per Employee	-179,062
Employee Count	910
Asset Turnover	0.27
Inventory Turnover	0.44

Taxes

Income Tax	-3.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.88% in the last 52 weeks. The beta is 0.20, so SHA:688266's price volatility has been lower than the market average.

Beta (5Y)	0.20
52-Week Price Change	+12.88%
50-Day Moving Average	87.83
200-Day Moving Average	103.46
Relative Strength Index (RSI)	69.60
Average Volume (20 Days)	3,435,467

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHA:688266 had revenue of CNY 810.48 million and -162.95 million in losses. Loss per share was -0.62.

Revenue	810.48M
Gross Profit	732.85M
Operating Income	-195.38M
Pretax Income	-168.65M
Net Income	-162.95M
EBITDA	-153.08M
EBIT	-195.38M
Loss Per Share	-0.62

Balance Sheet

The company has 2.03 billion in cash and 1.13 billion in debt, with a net cash position of 898.42 million or 3.39 per share.

Cash & Cash Equivalents	2.03B
Total Debt	1.13B
Net Cash	898.42M
Net Cash Per Share	3.39
Equity (Book Value)	1.08B
Book Value Per Share	4.08
Working Capital	1.02B

Cash Flow

In the last 12 months, operating cash flow was -28.78 million and capital expenditures -181.47 million, giving a free cash flow of -210.25 million.

Operating Cash Flow	-28.78M
Capital Expenditures	-181.47M
Depreciation & Amortization	42.30M
Net Borrowing	116.98M
Free Cash Flow	-210.25M
FCF Per Share	-0.79

Margins

Gross margin is 90.42%, with operating and profit margins of -24.11% and -20.10%.

Gross Margin	90.42%
Operating Margin	-24.11%
Pretax Margin	-20.81%
Profit Margin	-20.10%
EBITDA Margin	-18.89%
EBIT Margin	-24.11%
FCF Margin	n/a

Dividends & Yields

SHA:688266 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.85%
Shareholder Yield	0.85%
Earnings Yield	-0.61%
FCF Yield	-0.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1